
Jeffrey S. Parkin
Examiner (ID: 6020, Phone: (571)272-0908 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1648, 1641, 1813 |
| Total Applications | 1732 |
| Issued Applications | 938 |
| Pending Applications | 260 |
| Abandoned Applications | 572 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18693040
[patent_doc_number] => 20230323425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => SAMPLE PREPARATION AND VIRAL DETECTION METHODS
[patent_app_type] => utility
[patent_app_number] => 18/041295
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041295
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041295 | SAMPLE PREPARATION AND VIRAL DETECTION METHODS | Aug 11, 2021 | Pending |
Array
(
[id] => 17259963
[patent_doc_number] => 20210372948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => VERSATILE DISPLAY SCAFFOLDS FOR PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/399492
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399492 | VERSATILE DISPLAY SCAFFOLDS FOR PROTEINS | Aug 10, 2021 | Pending |
Array
(
[id] => 18142440
[patent_doc_number] => 20230016284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => IMMUNOGENIC TRIMERS
[patent_app_type] => utility
[patent_app_number] => 17/399501
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399501 | IMMUNOGENIC TRIMERS | Aug 10, 2021 | Pending |
Array
(
[id] => 18142440
[patent_doc_number] => 20230016284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => IMMUNOGENIC TRIMERS
[patent_app_type] => utility
[patent_app_number] => 17/399501
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399501 | IMMUNOGENIC TRIMERS | Aug 10, 2021 | Pending |
Array
(
[id] => 17371376
[patent_doc_number] => 20220026428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => DETECTION OF ANTIBODIES TO SARSR-COV
[patent_app_type] => utility
[patent_app_number] => 17/444223
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/444223 | DETECTION OF ANTIBODIES TO SARSR-COV | Aug 1, 2021 | Abandoned |
Array
(
[id] => 17291012
[patent_doc_number] => 20210386851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => MATERIALS AND METHODS FOR DETECTING, PREVENTING, AND TREATING RETROVIRAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/444242
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/444242 | MATERIALS AND METHODS FOR DETECTING, PREVENTING, AND TREATING RETROVIRAL INFECTION | Aug 1, 2021 | Abandoned |
Array
(
[id] => 18996181
[patent_doc_number] => 11913013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Chimpanzee adenoviral vector-based filovirus vaccines
[patent_app_type] => utility
[patent_app_number] => 17/389421
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 28
[patent_no_of_words] => 9885
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389421
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389421 | Chimpanzee adenoviral vector-based filovirus vaccines | Jul 29, 2021 | Issued |
Array
(
[id] => 17400026
[patent_doc_number] => 20220042116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => METHODS FOR ASSESSING VIRAL CLEARANCE
[patent_app_type] => utility
[patent_app_number] => 17/390252
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390252
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390252 | METHODS FOR ASSESSING VIRAL CLEARANCE | Jul 29, 2021 | Abandoned |
Array
(
[id] => 18809033
[patent_doc_number] => 20230383368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => A DETECTION METHOD FOR VIRAL REPLICATION
[patent_app_type] => utility
[patent_app_number] => 18/018488
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018488
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018488 | A DETECTION METHOD FOR VIRAL REPLICATION | Jul 26, 2021 | Pending |
Array
(
[id] => 18693066
[patent_doc_number] => 20230323455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHODS FOR ASSESSING THE SEVERITY AND PROGRESSION OF SARS-COV2 INFECTIONS USING CELL-FREE DNA
[patent_app_type] => utility
[patent_app_number] => 18/017165
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017165
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017165 | METHODS FOR ASSESSING THE SEVERITY AND PROGRESSION OF SARS-COV2 INFECTIONS USING CELL-FREE DNA | Jul 22, 2021 | Pending |
Array
(
[id] => 18161373
[patent_doc_number] => 20230027965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/376276
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/376276 | Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies | Jul 14, 2021 | Issued |
Array
(
[id] => 17228616
[patent_doc_number] => 20210355172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOSITIONS AND METHODS FOR EXOSOME TARGETED EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/305749
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305749
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305749 | HIV/SIV Nef fusion proteins for exosome targeted expression | Jul 13, 2021 | Issued |
Array
(
[id] => 18567499
[patent_doc_number] => 20230257833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => SAMPLING KITS AND METHODS FOR DETECTING RESPIRATORY PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 18/014645
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014645
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014645 | SAMPLING KITS AND METHODS FOR DETECTING RESPIRATORY PATHOGENS | Jul 13, 2021 | Pending |
Array
(
[id] => 18102445
[patent_doc_number] => 11542320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Nucleic acids encoding single domain antibodies to chikungunya virus
[patent_app_type] => utility
[patent_app_number] => 17/245180
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 2495
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245180
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245180 | Nucleic acids encoding single domain antibodies to chikungunya virus | Jul 8, 2021 | Issued |
Array
(
[id] => 17357183
[patent_doc_number] => 20220017979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS OF DETECTING SARS-COV-2, INFLUENZA, AND RSV
[patent_app_type] => utility
[patent_app_number] => 17/358523
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358523 | METHODS OF DETECTING SARS-COV-2, INFLUENZA, AND RSV | Jun 24, 2021 | Pending |
Array
(
[id] => 17357183
[patent_doc_number] => 20220017979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS OF DETECTING SARS-COV-2, INFLUENZA, AND RSV
[patent_app_type] => utility
[patent_app_number] => 17/358523
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358523 | METHODS OF DETECTING SARS-COV-2, INFLUENZA, AND RSV | Jun 24, 2021 | Pending |
Array
(
[id] => 17156118
[patent_doc_number] => 20210317169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => STABILIZED HUMAN IMMUNODEFICIENCY VIRUS (HIV) ENVELOPE (ENV) TRIMER VACCINES AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/304557
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304557
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304557 | STABILIZED HUMAN IMMUNODEFICIENCY VIRUS (HIV) ENVELOPE (ENV) TRIMER VACCINES AND METHODS OF USING SAME | Jun 22, 2021 | Abandoned |
Array
(
[id] => 18567464
[patent_doc_number] => 20230257798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHOD FOR PROVIDING PREPARATION FOR DETECTING TARGET NUCLEIC ACID SEQUENCE IN SPECIMEN
[patent_app_type] => utility
[patent_app_number] => 18/011678
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011678 | METHOD FOR PROVIDING PREPARATION FOR DETECTING TARGET NUCLEIC ACID SEQUENCE IN SPECIMEN | Jun 20, 2021 | Pending |
Array
(
[id] => 18755327
[patent_doc_number] => 20230358758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => Assay for the detection of the Cys-like protease (Mpro) of SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 18/008938
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008938 | Assay for the detection of the Cys-like protease (Mpro) of SARS-CoV-2 | Jun 7, 2021 | Pending |
Array
(
[id] => 20421274
[patent_doc_number] => 20250383359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-18
[patent_title] => COVID-19 Mucosal Antibody Assay
[patent_app_type] => utility
[patent_app_number] => 18/005332
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005332 | COVID-19 Mucosal Antibody Assay | Jun 2, 2021 | Pending |